The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Resisting the reality of chronic illness can lead to emotional distress. Acceptance, on the other hand, can open the door to proactive coping.

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

In line with President Ferdinand Marcos Jr.'s assurance of continuous expansion in healthcare benefits despite zero subsidy, the Philippine Health Insurance Corporation (PhilHealth) has substantially ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Living-donor transplantation is an option for some organs. For people over 18 born with two functioning kidneys, they can ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug ...

Sixteen-year-old Colette Nwachukwu is appealing for financial assistance to undergo surgery after being diagnosed with advanced ...

The Philippine Health Insurance Corporation (PhilHealth) has expanded the Z Benefit package for Peritoneal Dialysis (PD) with ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...